Profil
Serge Timsit is the founder of AVCare SAS, founded in 2019, and Neurokin SA, founded in 2003.
At Neurokin SA, he held the title of Director from 2009 to 2014.
Dr. Timsit's former job was at NeuroTECH SA, where he held the title of Principal.
Anciens postes connus de Serge Timsit
| Sociétés | Poste | Fin |
|---|---|---|
Neurokin SA
 Neurokin SA BiotechnologyHealth Technology Neurokin is a venture-back bio-tech company based in Marseilles, France. Neurokin is specializing in the development of different pharmacological in vitro platforms and in vivo experimental models related to acute neurological diseases. Neurokin's major objective is to identify new CDK inhibitors as neuroprotectants. Neurokin focuses on stroke, epilepsy, cerebral hypoxia after cardiac arrest and traumatic brain injury. As of May 2009, Neurokin has identified new neuroprotective drug candidates and has brought them to the regulatory preclinical stage. | Fondateur | 11/03/2014 |
AVCare SAS
 AVCare SAS BiotechnologyHealth Technology AVCare SAS engages in biotechnology research and development. It operates in the development of stroke blood biomarker. The company was founded by Serge Timsit and Jean-Marc Herbert on October 01, 2019 and is headquartered in Brest, France. | Fondateur | - |
NeuroTECH SA
 NeuroTECH SA Medical SpecialtiesHealth Technology Neurotech's founders have many years of experience in the development of innovative (cochlear) implants and implantable recording/stimulation electrodes. Neurotech SA was incorporated in 1996 to design, develop, manufacture and market active implantable medical devices for the treatment of debilitating disorders by neurostimulation. The Company, in the heart of Europe near Brussels, has since acquired significant expertise in applied biomedical technology. | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Neurokin SA
Neurokin SA BiotechnologyHealth Technology Neurokin is a venture-back bio-tech company based in Marseilles, France. Neurokin is specializing in the development of different pharmacological in vitro platforms and in vivo experimental models related to acute neurological diseases. Neurokin's major objective is to identify new CDK inhibitors as neuroprotectants. Neurokin focuses on stroke, epilepsy, cerebral hypoxia after cardiac arrest and traumatic brain injury. As of May 2009, Neurokin has identified new neuroprotective drug candidates and has brought them to the regulatory preclinical stage. | Health Technology |
NeuroTECH SA
NeuroTECH SA Medical SpecialtiesHealth Technology Neurotech's founders have many years of experience in the development of innovative (cochlear) implants and implantable recording/stimulation electrodes. Neurotech SA was incorporated in 1996 to design, develop, manufacture and market active implantable medical devices for the treatment of debilitating disorders by neurostimulation. The Company, in the heart of Europe near Brussels, has since acquired significant expertise in applied biomedical technology. | Health Technology |
AVCare SAS
AVCare SAS BiotechnologyHealth Technology AVCare SAS engages in biotechnology research and development. It operates in the development of stroke blood biomarker. The company was founded by Serge Timsit and Jean-Marc Herbert on October 01, 2019 and is headquartered in Brest, France. | Health Technology |
